CCR-3 receptor antagonists (I)
US7019007B2 · kind B2 · utility
2Cited by
3References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 2002 |
| Grant date | Mar 28, 2006 |
| Priority date | — |
| Expiry date | Nov 29, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds of Formula (I): wherein: R1–R4, A, D, and L have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermediates useful for preparing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.